PortfoliosLab logoPortfoliosLab logo
FLXS vs. AMRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FLXS vs. AMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Flexsteel Industries, Inc. (FLXS) and Amneal Pharmaceuticals, Inc. (AMRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FLXS achieves a 64.91% return, which is significantly higher than AMRX's 27.86% return. Over the past 10 years, FLXS has outperformed AMRX with an annualized return of 7.74%, while AMRX has yielded a comparatively lower -5.79% annualized return.


FLXS

1D
-0.02%
1M
15.35%
YTD
64.91%
6M
61.47%
1Y
84.86%
3Y*
54.13%
5Y*
11.05%
10Y*
7.74%

AMRX

1D
-0.62%
1M
29.71%
YTD
27.86%
6M
25.66%
1Y
106.01%
3Y*
77.51%
5Y*
25.09%
10Y*
-5.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FLXS vs. AMRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FLXS
Flexsteel Industries, Inc.
64.91%-25.95%192.93%26.12%-40.70%-21.76%80.92%-5.52%-51.45%-22.83%
AMRX
Amneal Pharmaceuticals, Inc.
27.86%59.09%30.48%205.03%-58.46%4.81%-5.19%-64.38%-18.74%25.66%

Correlation

The correlation between FLXS and AMRX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jan 15, 2009

0.17

Fundamentals

Market Cap

FLXS:

$365.18M

AMRX:

$5.30B

EPS

FLXS:

$5.52

AMRX:

$0.38

PE Ratio

FLXS:

11.74

AMRX:

42.82

PEG Ratio

FLXS:

0.06

AMRX:

1.49

PS Ratio

FLXS:

0.80

AMRX:

1.72

PB Ratio

FLXS:

1.26

AMRX:

6.90

Total Revenue (TTM)

FLXS:

$458.42M

AMRX:

$3.05B

Gross Profit (TTM)

FLXS:

$106.25M

AMRX:

$1.18B

EBITDA (TTM)

FLXS:

$42.45M

AMRX:

$626.02M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FLXS vs. AMRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FLXS
FLXS Risk / Return Rank: 8181
Overall Rank
FLXS Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
FLXS Sortino Ratio Rank: 8484
Sortino Ratio Rank
FLXS Omega Ratio Rank: 8181
Omega Ratio Rank
FLXS Calmar Ratio Rank: 8080
Calmar Ratio Rank
FLXS Martin Ratio Rank: 7777
Martin Ratio Rank

AMRX
AMRX Risk / Return Rank: 9393
Overall Rank
AMRX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMRX Sortino Ratio Rank: 9595
Sortino Ratio Rank
AMRX Omega Ratio Rank: 9494
Omega Ratio Rank
AMRX Calmar Ratio Rank: 9191
Calmar Ratio Rank
AMRX Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FLXS vs. AMRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Flexsteel Industries, Inc. (FLXS) and Amneal Pharmaceuticals, Inc. (AMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FLXSAMRXDifference
Sharpe ratioReturn per unit of total volatility

-1.71

Sortino ratioReturn per unit of downside risk

-1.42

Omega ratioGain probability vs. loss probability

1.30

1.50

-0.20

Calmar ratioReturn relative to maximum drawdown

2.54

4.79

-2.26

Martin ratioReturn relative to average drawdown

5.18

11.85

-6.67

FLXS vs. AMRX - Sharpe Ratio Comparison

The current FLXS Sharpe Ratio is 1.60, which is lower than the AMRX Sharpe Ratio of 3.32. The chart below compares the historical Sharpe Ratios of FLXS and AMRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FLXS vs. AMRX - Drawdown Comparison

The maximum FLXS drawdown since its inception was -85.58%, smaller than the maximum AMRX drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for FLXS and AMRX.


Loading charts...

Drawdown Indicators


FLXSAMRXDifference

Max Drawdown

Largest peak-to-trough decline

-85.58%

-97.52%

+11.94%

Max Drawdown (1Y)

Largest decline over 1 year

-33.65%

-22.25%

-11.40%

Max Drawdown (3Y)

Largest decline over 3 years

-54.10%

-26.80%

-27.30%

Max Drawdown (5Y)

Largest decline over 5 years

-68.15%

-78.29%

+10.14%

Max Drawdown (10Y)

Largest decline over 10 years

-85.58%

-95.98%

+10.40%

Current Drawdown

Current decline from peak

-0.02%

-68.60%

+68.58%

Average Drawdown

Average peak-to-trough decline

-28.94%

-54.34%

+25.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.44%

8.98%

+7.46%

Volatility

FLXS vs. AMRX - Volatility Comparison

Flexsteel Industries, Inc. (FLXS) and Amneal Pharmaceuticals, Inc. (AMRX) have volatilities of 12.01% and 11.49%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FLXSAMRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.01%

11.49%

+0.52%

Volatility (6M)

Calculated over the trailing 6-month period

39.80%

24.31%

+15.49%

Volatility (1Y)

Calculated over the trailing 1-year period

53.33%

32.20%

+21.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.44%

50.98%

+4.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.80%

65.26%

-13.46%

Dividends

FLXS vs. AMRX - Dividend Comparison

FLXS's dividend yield for the trailing twelve months is around 1.23%, while AMRX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMRX
Amneal Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FLXS
Flexsteel Industries, Inc.
1.23%1.95%1.18%3.18%3.90%2.23%1.20%4.42%3.99%1.80%1.23%1.63%

Financials

FLXS vs. AMRX - Financials Comparison

This section allows you to compare key financial metrics between Flexsteel Industries, Inc. and Amneal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
115.13M
722.52M
(FLXS) Total Revenue
(AMRX) Total Revenue
Values in USD except per share items

FLXS vs. AMRX - Profitability Comparison

The chart below illustrates the profitability comparison between Flexsteel Industries, Inc. and Amneal Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%20222023202420252026
22.6%
44.3%
Portfolio components
FLXS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Flexsteel Industries, Inc. reported a gross profit of 26.05M and revenue of 115.13M. Therefore, the gross margin over that period was 22.6%.

AMRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 320.11M and revenue of 722.52M. Therefore, the gross margin over that period was 44.3%.

FLXS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Flexsteel Industries, Inc. reported an operating income of 8.22M and revenue of 115.13M, resulting in an operating margin of 7.1%.

AMRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported an operating income of 133.54M and revenue of 722.52M, resulting in an operating margin of 18.5%.

FLXS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Flexsteel Industries, Inc. reported a net income of 6.45M and revenue of 115.13M, resulting in a net margin of 5.6%.

AMRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a net income of 62.50M and revenue of 722.52M, resulting in a net margin of 8.7%.


Frequently Asked Questions


FLXS and AMRX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FLXS has higher volatility (12.01%) compared to AMRX (11.49%). In terms of maximum drawdown, FLXS dropped -85.58% vs AMRX's -97.52%.

AMRX currently has the higher Sharpe Ratio (3.32 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FLXS and AMRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer